This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

  Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 25, 2014

|Home|   |About the SDSS|   |Join SDSS|   |Member Benefits|   |Bookstore|   |Political Advocacy|  
|National Certification for Skin Care Professionals|   |SDSS Corporate Members|   |Online Continuing Education|


The International Congress of Esthetics and Spa
Registration now open for Arlington, Texas

Saturday, May 3
Arlington Convention Center
Dallas, Texas

Who should attend?

If you are an educator working for a manufacturer/distributor, a teacher at a school or wanting to improve your on-site staff training by understanding learning styles, then this event is for you!

Who should attend?
NETT will give you the edge, recharge your skills and give you the opportunity to network with like-minded professionals.

Cost $125 NCEA members; $149 nonmembers


  • Two-day all inclusive admission to The International Congress of Esthetics and Spa.
  • 5 CEs Approved by the Commission on Accreditation.
  • CE Certificate and Digital Course Materials.
  • Complimentary NCEA Certified Records Verification ($175 value).
  • Certificate of Attendance from the International Congress of Esthetics and Spa.

  • Click "Read More" for more information about the convention and class offerings.
       Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Free dermatology drug samples come at a cost
    Dermatologists tend to prescribe more expensive medications when they also give their patients drug samples, according to a new U.S. study. "If you're a patient who receives a sample, you may perceive that doctor is giving you better care because they gave you a gift," Dr. Alfred Lane told Reuters Health. "But that doctor may have increased your medical costs by giving you that sample."
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Reconstitution is key to optimizing neurotoxin results
    Dermatology Times
    IncobotulinumtoxinA is equivalent to onabotulinumtoxinA in efficacy and safety, but the former product needs to be reconstituted in a different fashion from onabotulinumtoxin A to achieve equivalent efficacy. "Although more than 3,000 patients in numerous studies show that both products are comparable, a small number of studies have shown incobotulinumtoxinA to be inferior to onabotulinumtoxinA," said Dr. Wayne Carey, associate professor of dermatology at McGill University, Montreal.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Exercise reverses skin aging: Hit the gym if you want to look 20s when in your 40s
    Tech Times
    Regular exercise is believed to keep one's skin glowing and now a study conducted by researchers at Canada's McMaster University in Hamilton, Ontario, reveals that it can result in the reduction of skin aging. Apparently, if one exercises frequently, the skin is not only younger looking, but the aging process is also reversed for those who start working out at an older age.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Scientist breaks through the body's intricate healing process
    University of Southern California
    A Keck School of Medicine of University of Southern California researcher has shown that a previously unsuspected but common protein in the human body can help wounds to the skin heal, contradicting decades of conventional wisdom about the biology of tissue repair as well as potential treatments.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Malfunction in molecular 'proofreader' prevents repair of UV-induced DNA damage
    Medical News Today
    Malfunctions in the molecular "proofreading" machinery, which repairs structural errors in DNA caused by ultraviolet light damage, help explain why people who have the disease xeroderma pigmentosum are at an extremely high risk for developing skin cancer, according to researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute. Their findings will be published in the early online version of the Proceedings of the National Academy of Sciences.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

      ULTRACARE®...the ONLY Disinfectant you need!
    Ultracare Disinfectant Cleaner/Deodorizer Concentrate is a medical-grade, dual-quaternary disinfectant that has been tested to kill 141 organisms, including HIV-1, HBV, and HCV. EPA-registered and complies with OSHA’s Blood borne Pathogens Standard as well as (CDC) guidelines. Ultracare® cleans and disinfects in one step and is effective in the presence of 98% organic soil. It conforms to state and local Board regulations. Call 1-800-262-6262 or visit out website at

    New clues to potential treatments for tissue scarring in scleroderma
    Skin Inc.
    A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma. Fibrosis, or scarring, is a hallmark of the disease, and progressive tightening of the skin and lungs can lead to serious organ damage and, in some cases, death. The concept for new therapeutic options centers on findings made by Dr. Swati Bhattacharyya, research assistant professor in Medicine-Rheumatology, who identified the role that a specific protein plays in promoting fibrosis.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Top destination choices for medical tourism in 2014
    By Archita Datta Majumdar
    The concept of medical tourism is an instant hit for two reasons: the promise of good treatment at half the cost and the added bonus of a vacation to a foreign land. Once the idea caught on, the travel and hospitality industry was quick to see the benefits of tying up with the medical community and expand the limits of this new business. According to the International Medical Travel Journal, 48 percent of the industry has seen a steady rise in international patient numbers in the last 12 months, while almost 76 percent expect more growth in the next 12 months.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

      AVANI is the latest in advanced skin-care

    Formulated from the very best ingredients that nature has to offer, AVANI's Dead Sea mineral-based products have been enriched with plant extracts, essential oils & vitamins to ensure healthy, radiant skin. AVANI's superb & innovative luxurious range of Dead Sea cosmetics offers you excellence in skin-care.

    Why telemedicine is the future of the health care industry
    This Fiscal Times via The Week
    The doctor will text you now. More than 40 years ago, large urban hospitals extended care to rural areas via an electronic communications system called telemedicine. Think of it as the ultimate reality show on closed-circuit TV, where a patient with, say, a skin disorder can show a doctor her rash and the doctor can call in the perfect medication to the local Walmart pharmacy.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Missed last week's issue? See which articles your colleagues read most.

        Is Botox safe in pregnancy? (Made for Mums)
    Self-tanning products: What you need to know (Information-Analytic Agency
    New hope for people with chronic skin conditions (WJXT-TV)
    Botox treatments for men grow in popularity (Financial Times)
    More brides relying on cosmetic procedures for perfection on their big day (Chattanooga Times Free Press)

    Don't be left behind. Click here to see what else you missed.

    Skin layer grown from human stem cells could replace animals in drug, cosmetics testing
    King's College London via Medical Xpress
    An international team led by King's College London and the San Francisco Veteran Affairs Medical Center has developed the first lab-grown epidermis with a functional permeability barrier akin to real skin. The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics, and could also help to develop new therapies for rare and common skin disorders.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    Looking for similar articles? Search here, keywords STEM CELLS.

    Beauty tips: Treatment for skin cancer
    The News-Press
    As baby boomers age, the effects of excessive sun exposure are coming to roost. Skin cancer is the most common form of cancer, with more than 3.5 million skin cancers detected in two million people annually.

    Share on FacebookTwitterShare on LinkedinE-mail article
    read more
    Study reveals complex role of largely unknown Mpzl3 gene
    Health Canal
    A multidisciplinary study led by Dr. Tongyu Cao Wikramanayake, research assistant professor of dermatology and cutaneous surgery, has pinpointed multiple roles of the little-known protein-coding gene Mpzl3.

    Share on FacebookTwitterShare on LinkedinE-mail article
    read more
    The 6 body parts that reveal your age
    The Huffington Post
    With age, your skin thins and grows less elastic. As a result, wrinkles, age spots and skin tags become more common. Generally speaking, you can promote healthier skin by bathing in warm — and not hot — water. You should also wear sunscreen and not smoke.

    Share on FacebookTwitterShare on LinkedinE-mail article
    read more

    Obesity in children linked with psoriasis diagnosis
    Dr. Amy S. Paller and colleagues of the department of dermatology and pediatrics at Northwestern University conducted a cohort study with 27 children who were overweight, obese and had psoriasis. Patients were recruited from three pediatric dermatology referral centers. The BMI percentiles of overweight children — 86th to 95th — and obese children — 96th and greater — were determined one and two years before psoriasis diagnosis, as well as one and two years after. The mean BMI percentile at baseline was 96th.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Cutaneous erythema predicted low-dose alemtuzumab response in leukemic cutaneous T-cell lymphoma
    The Oncology Report
    In patients with leukemic cutaneous T-cell lymphoma, diffuse cutaneous erythema without plaques or tumors predicted complete remission with low-dose alemtuzumab therapy, investigators reported in a JAMA Dermatology research letter. "Initial clinical presentation was more predictive of response than was complex cellular phenotyping of T cells from blood and skin," wrote Dr. Rei Watanabe at Brigham and Women's Hospital in Boston and associates. "In other words, the eyes of a well-trained dermatologist were more powerful than a comprehensive translational research program in identifying complete responders to low-dose alemtuzumab therapy."
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

     Member Benefit

    15% Discount for Online Courses

    As an SDSS member, the American Health Care Academy is offering a 15% discount for Adult, Child & Infant CPR/AED, and First Aid online courses.

    To receive this discount, click here and enter "SDSS15" at checkout under "Coupon Code," then click "Apply."

    Please note: To meet the CPR/AED/First Aid requirements on the NCEA Certified Candidate's Application and Recertification Candidate's Application, candidates are required to attend an in-person class once every five years. Be sure to check and see if your State Regulatory Board requirements accept online CPR/AED/First Aid courses prior to taking advantage of this offer.

    For more information on becoming NCEA Certified or the Recertification Application process go to

    Become an SDSS member — Join Now!

     Continuing Education

    CE Articles from
    MELANOMA: COA#PCIA1013   Exp. 11/1/2017  This educational activity has been approved for 1.0 CEs.   Download article and test.

    Learning objectives
    After reading this article and taking this test, the skin care professional will be able to:
    1. Understand the cause of Melanoma cancer and how to reduce risk.
    2. Understand the treatment options currently available.

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Susanne S. Warfield, President/CEO of Paramedical Consultants, Inc. ( Official Publication of the Society of Dermatology SkinCare Specialists. Warfield has more than 33 years' experience, is a leading expert on business, legal and liability issues that affect physician and esthetician relationships. She has authored more than 450 articles and 15 books for the consumer, medical and skin care sectors. She is the recipient of the prestigious Crystal Award for Life Achievement by Les Nouvelles Esthétiques & Spa.More



    Warfield Weekly Update
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Rebecca Eberhardt, Content Editor, 469.420.2608   
    Contribute news

    This edition of Warfield Weekly Update was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
    Recent issues
    April 18, 2014
    April 11, 2014
    April 4, 2014
    March 28, 2014

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063